Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Reference on EC 3.4.23.47 - HIV-2 retropepsin

Please use the Reference Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Wu, J.C.; Carr, S.F.; Jarnagin, K.; Kirsher, S.; Barnett, J.; Chow, J.; Chan, H.W.; Chen, M.S.; Medzihradszky, D.; Yamashiro, D.; et al.
Synthetic HIV-2 protease cleaves the GAG precursor of HIV-1 with the same specificity as HIV-1 protease
Arch. Biochem. Biophys.
277
306-311
1990
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Gustchina, A.; Weber, I.T.; Wlodawer, A.
Molecular modeling of the HIV-2 protease
Adv. Exp. Med. Biol.
306
549-553
1991
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Toezser, J.; Blaha, I.; Copeland, T.D.; Wondrak, E.M.; Oroszlan, S.
Comparison of the HIV-1 and HIV-2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag-Pol polyproteins
FEBS Lett.
281
77-80
1991
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Rose, J.R.; Salto, R.; Craik, C.S.
Regulation of autoproteolysis of the HIV-1 and HIV-2 proteases with engineered amino acid substitutions
J. Biol. Chem.
268
11939-11945
1993
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Tong, L.; Pav, S.; Pargellis, C.; Do, F.; Lamarre, D.; Anderson, P.C.
Crystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced amide inhibitor and comparison with HIV-1 protease structures
Proc. Natl. Acad. Sci. USA
90
8387-8391
1993
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Chen, Z.; Li, Y.; Chen, E.; Hall, D.L.; Darke, P.L.; Culberson, C.; Shafer, J.A.; Kuo, L.C.
Crystal structure at 1.9-A resolution of human immunodeficiency virus (HIV) II protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases
J. Biol. Chem.
269
26344-26348
1994
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Griffiths, J.T.; Tomchak, L.A.; Mills, J.S.; Graves, M.C.; Cook, N.D.; Dunn, B.M.; Kay, J.
Interactions of substrates and inhibitors with a family of tethered HIV-1 and HIV-2 homo- and heterodimeric proteinases
J. Biol. Chem.
269
4787-4793
1994
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Fan, N.; Rank, K.B.; Leone, J.W.; Heinrikson, R.L.; Bannow, C.A.; Smith, C.W.; Evans, D.B.; Poppe, S.M.; Tarpley, W.G.
The differential processing of homodimers of reverse transcriptases from human immunodeficiency viruses type 1 and 2 is a consequence of the distinct specificities of the viral proteases
J. Biol. Chem.
270
13573-13579
1995
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Tong, L.; Pav, S.; Mui, S.; Lamarre, D.; Yoakim, C.; Beaulieu, P.; Anderson, P.C.
Crystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere
Structure
3
33-40
1995
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Bagossi, P.; Cheng, Y.S.E.; Oroszlan, S.; Toezser, J.
Comparison of the specificity of homo- and heterodimeric linked HIV-1 and HIV-2 proteinase dimers
Protein Eng.
11
439-445
1998
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Lescar, J.; Brynda, J.; Rezacova, P.; Stouracova, R.; Riottot, M.M.; Chitarra, V.; Fabry, M.; Horejsi, M.; Sedlacek, J.; Bentley, G.A.
Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody
Protein Sci.
8
2686-2696
1999
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Davis, D.A.; Newcomb, F.M.; Moskovitz, J.; Wingfield, P.T.; Stahl, S.J.; Kaufman, J.; Fales, H.M.; Levine, R.L.; Yarchoan, R.
HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase
Biochem. J.
346
305-311
2000
Human immunodeficiency virus 2
-
Manually annotated by BRENDA team
Davis, D.A.; Newcomb, F.M.; Moskovitz, J.; Fales, H.M.; Levine, R.L.; Yarchoan, R.
Reversible oxidation of HIV-2 protease
Methods Enzymol.
348
249-259
2002
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Dunn, B.M.
Human immunodeficiency virus 2 retropepsin
Handbook of Proteolytic Enzymes (Barrett, A. J. ; Rowlings, N. D. ; Woessner, J. F. , eds. )
1
154-157
2004
Human immunodeficiency virus 2
-
Manually annotated by BRENDA team
Bagossi, P.; Sperka, T.; Feher, A.; Kadas, J.; Zahuczky, G.; Miklossy, G.; Boross, P.; Toezser, J.
Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites
J. Virol.
79
4213-4218
2005
Human immunodeficiency virus 2 (P04584)
Manually annotated by BRENDA team
Alvarez, E.; Castello, A.; Menendez-Arias, L.; Carrasco, L.
HIV protease cleaves poly(A)-binding protein
Biochem. J.
396
219-226
2006
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Masse, S.; Lu, X.; Dekhtyar, T.; Lu, L.; Koev, G.; Gao, F.; Mo, H.; Kempf, D.; Bernstein, B.; Hanna, G.J.; Molla, A.
In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavir
Antimicrob. Agents Chemother.
51
3075-3080
2007
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Ntemgwa, M.; Brenner, B.G.; Oliveira, M.; Moisi, D.; Wainberg, M.A.
Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors
Antimicrob. Agents Chemother.
51
604-610
2007
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Ruelle, J.; Roman, F.; Vandenbroucke, A.T.; Lambert, C.; Fransen, K.; Echahidi, F.; Pierard, D.; Verhofstede, C.; Van Laethem, K.; Delforge, M.L.; Vaira, D.; Schmit, J.C.; Goubau, P.
Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database
BMC Infect. Dis.
8
21
2008
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Brower, E.T.; Bacha, U.M.; Kawasaki, Y.; Freire, E.
Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use
Chem. Biol. Drug Des.
71
298-305
2008
Human immunodeficiency virus 2
Manually annotated by BRENDA team
MBarek, N.B.; Audoly, G.; Raoult, D.; Gluschankof, P.
HIV-2 Protease resistance defined in yeast cells
Retrovirology
3
58
2006
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Louis, J.M.; Ishima, R.; Aniana, A.; Sayer, J.M.
Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease
Protein Sci.
18
2442-2453
2009
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Tie, Y.; Wang, Y.F.; Boross, P.I.; Chiu, T.Y.; Ghosh, A.K.; Tozser, J.; Louis, J.M.; Harrison, R.W.; Weber, I.T.
Critical differences in HIV-1 and HIV-2 protease specificity for clinical inhibitors
Protein Sci.
21
339-350
2012
Human immunodeficiency virus 2
Manually annotated by BRENDA team
Chen, J.; Liang, Z.; Wang, W.; Yi, C.; Zhang, S.; Zhang, Q.
Revealing origin of decrease in potency of darunavir and amprenavir against HIV-2 relative to HIV-1 protease by molecular dynamics simulations
Sci. Rep.
4
6872
2014
HIV-2 subtype A (P04584)
Manually annotated by BRENDA team
Cong, Y.; Li, Y.; Jin, K.; Zhong, S.; Zhang, J.Z.H.; Li, H.; Duan, L.
Exploring the reasons for decrease in binding affinity of HIV-2 against HIV-1 protease complex using interaction entropy under polarized force field
Front. Chem.
6
380
2018
Human immunodeficiency virus 2 (P04584)
Manually annotated by BRENDA team
Triki, D.; Fartek, S.; Visseaux, B.; Descamps, D.; Camproux, A.C.; Regad, L.
Characterizing the structural variability of HIV-2 protease upon the binding of diverse ligands using a structural alphabet approach
J. Biomol. Struct. Dyn.
37
4658-4670
2018
Human immunodeficiency virus 2 (P04584), Human immunodeficiency virus 2
Manually annotated by BRENDA team
Raugi, D.N.; Smith, R.A.; Gottlieb, G.S.; Gottlieb, G.S.
Four amino acid changes in HIV-2 protease confer class-wide sensitivity to protease inhibitors
J. Virol.
90
1062-1069
2016
Human immunodeficiency virus 2 (P04584), Human immunodeficiency virus 2
Manually annotated by BRENDA team
Triki, D.; Billot, T.; Visseaux, B.; Descamps, D.; Flatters, D.; Camproux, A.C.; Regad, L.
Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases
Sci. Rep.
8
5789
2018
Human immunodeficiency virus 2 (P04584), Human immunodeficiency virus 2
Manually annotated by BRENDA team
Triki, D.; Cano Contreras, M.E.; Flatters, D.; Visseaux, B.; Descamps, D.; Camproux, A.C.; Regad, L.
Analysis of the HIV-2 proteases adaptation to various ligands characterization of backbone asymmetry using a structural alphabet
Sci. Rep.
8
710
2018
Human immunodeficiency virus 2 (P04584), Human immunodeficiency virus 2
Manually annotated by BRENDA team